Description:SRT1720HCl, with the CAS number 1001645-58-4, is a synthetic compound that acts as a selective SIRT1 (sirtuin 1) activator. It is primarily studied for its potential effects on metabolism, aging, and various age-related diseases. The compound is known to enhance mitochondrial function and promote cellular health by mimicking the effects of caloric restriction, which is associated with increased lifespan in various organisms. SRT1720HCl is typically characterized by its ability to modulate pathways related to energy homeostasis and inflammation. In research settings, it has been investigated for its potential therapeutic applications in metabolic disorders, neurodegenerative diseases, and cancer. The hydrochloride salt form (HCl) enhances its solubility in aqueous solutions, making it suitable for biological studies. As with many experimental compounds, the safety profile and long-term effects of SRT1720HCl require further investigation to fully understand its implications in clinical settings.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide dihydroc…](https://static.cymitquimica.com/products/10/thumb/F546090.jpg)
